Stay updated on Sorafenib Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T06:32:15.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new clinical trial identifiers and collaborators, while removing detailed descriptions of the trial objectives and methodologies. Notably, the principal investigator's name has been retained.
    Difference
    46%
    Check dated 2025-04-16T20:44:37.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4 and removed a date of 2025-03-25 while adding new dates of 2024-12-27 and 2025-02-11.
    Difference
    0.4%
    Check dated 2025-04-09T16:02:33.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and the removal of estimated dates for results and updates, indicating a shift to more definitive information.
    Difference
    0.4%
    Check dated 2025-04-02T00:40:31.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-02-24T23:19:01.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new study results and protocols, including specific details about the safety and efficacy of treatments for participants with Child-Pugh B liver function. Key dates for results posting have also been revised.
    Difference
    43%
    Check dated 2025-02-17T19:40:44.000Z thumbnail image

Stay in the know with updates to Sorafenib Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.